Hollsteen
← Alphabet

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: $123.6B · 10-Q 0001652044-16-000021 filed May 3, 2016Equity incl. NCI · Q2 2016: $127.9B · 10-Q 0001652044-16-000032 filed Aug 4, 2016Equity incl. NCI · Q3 2016: $134.1B · 10-Q 0001652044-16-000038 filed Nov 3, 2016Equity incl. NCI · Q4 2016: $139.0B · 10-K 0001652044-17-000008 filed Feb 3, 2017Equity incl. NCI · Q1 2017: $144.9B · 10-Q 0001652044-17-000014 filed May 2, 2017Equity incl. NCI · Q2 2017: $148.3B · 10-Q 0001652044-17-000026 filed Jul 25, 2017Equity incl. NCI · Q3 2017: $157.1B · 10-Q 0001652044-17-000042 filed Oct 27, 2017Equity incl. NCI · Q4 2017: $152.5B · 10-K 0001652044-18-000007 filed Feb 6, 2018Equity incl. NCI · Q1 2018: $160.8B · 10-Q 0001652044-18-000016 filed Apr 24, 2018Equity incl. NCI · Q2 2018: $162.0B · 10-Q 0001652044-18-000027 filed Jul 24, 2018Equity incl. NCI · Q3 2018: $169.8B · 10-Q 0001652044-18-000035 filed Oct 26, 2018Equity incl. NCI · Q4 2018: $177.6B · 10-K 0001652044-19-000004 filed Feb 5, 2019Equity incl. NCI · Q1 2019: $183.5B · 10-Q 0001652044-19-000015 filed Apr 30, 2019Equity incl. NCI · Q2 2019: $192.2B · 10-Q 0001652044-19-000023 filed Jul 26, 2019Equity incl. NCI · Q3 2019: $195.0B · 10-Q 0001652044-19-000032 filed Oct 29, 2019Equity incl. NCI · Q4 2019: $201.4B · 10-K 0001652044-20-000008 filed Feb 4, 2020Equity incl. NCI · Q1 2020: $203.7B · 10-Q 0001652044-20-000021 filed Apr 29, 2020Equity incl. NCI · Q2 2020: $207.3B · 10-Q 0001652044-20-000032 filed Jul 31, 2020Equity incl. NCI · Q3 2020: $212.9B · 10-Q 0001652044-20-000050 filed Oct 30, 2020Equity incl. NCI · Q4 2020: $222.5B · 10-K 0001652044-21-000010 filed Feb 3, 2021Equity incl. NCI · Q1 2021: $230.0B · 10-Q 0001652044-21-000020 filed Apr 28, 2021Equity incl. NCI · Q2 2021: $237.6B · 10-Q 0001652044-21-000047 filed Jul 28, 2021Equity incl. NCI · Q3 2021: $244.6B · 10-Q 0001652044-21-000057 filed Oct 27, 2021Equity incl. NCI · Q4 2021: $251.6B · 10-K 0001652044-22-000019 filed Feb 2, 2022Equity incl. NCI · Q1 2022: $254.0B · 10-Q 0001652044-22-000029 filed Apr 27, 2022Equity incl. NCI · Q2 2022: $255.4B · 10-Q 0001652044-22-000071 filed Jul 27, 2022Equity incl. NCI · Q3 2022: $253.6B · 10-Q 0001652044-22-000090 filed Oct 26, 2022Equity incl. NCI · Q4 2022: $256.1B · 10-K 0001652044-23-000016 filed Feb 3, 2023Equity incl. NCI · Q1 2023: $260.9B · 10-Q 0001652044-23-000045 filed Apr 26, 2023Equity incl. NCI · Q2 2023: $267.1B · 10-Q 0001652044-23-000070 filed Jul 26, 2023Equity incl. NCI · Q3 2023: $273.2B · 10-Q 0001652044-23-000094 filed Oct 25, 2023Equity incl. NCI · Q4 2023: $283.4B · 10-K 0001652044-24-000022 filed Jan 31, 2024Equity incl. NCI · Q1 2024: $292.8B · 10-Q 0001652044-24-000053 filed Apr 26, 2024Equity incl. NCI · Q2 2024: $300.8B · 10-Q 0001652044-24-000079 filed Jul 24, 2024Equity incl. NCI · Q3 2024: $314.1B · 10-Q 0001652044-24-000118 filed Oct 30, 2024Equity incl. NCI · Q4 2024: $325.1B · 10-K 0001652044-25-000014 filed Feb 5, 2025Equity incl. NCI · Q1 2025: $345.3B · 10-Q 0001652044-25-000043 filed Apr 25, 2025Equity incl. NCI · Q2 2025: $362.9B · 10-Q 0001652044-25-000062 filed Jul 24, 2025Equity incl. NCI · Q3 2025: $386.9B · 10-Q 0001652044-25-000091 filed Oct 30, 2025Equity incl. NCI · Q4 2025: $415.3B · 10-K 0001652044-26-000018 filed Feb 5, 2026Equity incl. NCI · Q1 2026: $478.7B · 10-Q 0001652044-26-000048 filed Apr 30, 2026Equity incl. NCI · Q2 2026: $640.5B · 10-Q 0001652044-26-000071 filed Jul 23, 2026157.1640.5123.6Q1 2016Q2 2026Q3 2017
Q3 2017
157.1$B
All values (42)
PeriodValue ($B)Status
Q2 2026640.5reported
Q1 2026478.7reported
Q4 2025415.3reported
Q3 2025386.9reported
Q2 2025362.9reported
Q1 2025345.3reported
Q4 2024325.1reported
Q3 2024314.1reported
Q2 2024300.8reported
Q1 2024292.8reported
Q4 2023283.4reported
Q3 2023273.2reported
Q2 2023267.1reported
Q1 2023260.9reported
Q4 2022256.1reported
Q3 2022253.6reported
Q2 2022255.4reported
Q1 2022254.0reported
Q4 2021251.6reported
Q3 2021244.6reported
Q2 2021237.6reported
Q1 2021230.0reported
Q4 2020222.5reported
Q3 2020212.9reported
Q2 2020207.3reported
Q1 2020203.7reported
Q4 2019201.4reported
Q3 2019195.0reported
Q2 2019192.2reported
Q1 2019183.5reported
Q4 2018177.6reported
Q3 2018169.8reported
Q2 2018162.0reported
Q1 2018160.8reported
Q4 2017152.5reported
Q3 2017157.1reported
Q2 2017148.3reported
Q1 2017144.9reported
Q4 2016139.0reported
Q3 2016134.1reported
Q2 2016127.9reported
Q1 2016123.6reported

CSV with all sources · Technical ID: equity_total

More metrics for Alphabet
Sources & calculation
Value
$157.1B
Period
Q3 2017, ended Sep 30, 2017 · as of Sep 30, 2017 (balance as of date, not a sum)
Source
10-Q, filed Oct 27, 2017 · 0001652044-17-000042
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$157.1BOct 27, 201710-Q 0001652044-17-000042reported · confidence 1. · current